Conatus Pharmaceuticals Inc. | Key People and Executives
Steven J. Mento
President, Chief Executive Officer & Director
Harold E. van Wart
Independent Director
James Paul Scopa
Independent Director
Daniel L. Kisner
Independent Director
Preston S. Klassen
Independent Director
William R. LaRue
Independent Director
Steven J. Mento
President, Chief Executive Officer & Director
Keith W. Marshall
Chief Operating & Financial Officer, Executive VP
Alfred P. Spada
CSO, Executive VP-Research & Development
Daniel L. Ripley
Senior VP-Business Development & Programme
David T. Hagerty
Executive Vice President-Clinical Development
Michelle L. Vandertie
Principal Accounting Officer & VP-Finance
Alan R. Engbring
Executive Director-IR & Communications
Michael M. Mueller
Secretary
Edward F. Smith
Senior VP-Regulatory Affairs & Quality Assurance
Harold E. van Wart
Independent Director
James Paul Scopa
Independent Director
Daniel L. Kisner
Independent Director
Preston S. Klassen
Independent Director
William R. LaRue
Independent Director
| Address |
16745 West Bernardo Drive
San Diego California 92127
United States
|
|
Employees
|
- |
| Website |
http://www.conatuspharma.com |
| Updated |
07/08/2019 |
| Conatus Pharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of liver diseases. It focuses in development of emricasan, an active pan-caspase protease inhibitor for the treatment of patients with chronic liver disease, which reduce the activities of human caspases. The company was founded by Alfred P. |
